Crossmark

Randomized, Placebo Controlled Trial of NPT088, A Phage-Derived, Amyloid-Targeted Treatment for Alzheimer's Disease

Crossref DOI link: https://doi.org/10.14283/jpad.2019.37

Published Print: 2019-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Michelson, D.

Grundman, M.

Magnuson, K.

Fisher, Richard

Levenson, J.M.

Aisen, P.

Marek, K.

Gray, M.

Hefti, F.
License Information

Text and Data Mining valid from 2019-10-01

Text and Data Mining valid from 2019-10-01

Version of Record valid from 2024-09-25
More Information

This article is maintained by: Elsevier

Article Title: Randomized, Placebo Controlled Trial of NPT088, A Phage-Derived, Amyloid-Targeted Treatment for Alzheimer's Disease

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2019.37

Content Type: article

Copyright: Copyright © 2019 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS